awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q31157714-19F16BE9-8FCE-46BF-83D1-7B88EE541E3D
Q31157714-19F16BE9-8FCE-46BF-83D1-7B88EE541E3D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q31157714-19F16BE9-8FCE-46BF-83D1-7B88EE541E3D
Clinical results of randomized trials and 'real-world' data exploring the impact of Bevacizumab for breast cancer: opportunities for clinical practice and perspectives for research.
P2860
Q31157714-19F16BE9-8FCE-46BF-83D1-7B88EE541E3D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q31157714-19F16BE9-8FCE-46BF-83D1-7B88EE541E3D
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
177fa6f1f213bb9f13dd5be17164dbcf24f2a964
P2860
Bevacizumab plus chemotherapy versus chemotherapy alone as second-line treatment for patients with HER2-negative locally recurrent or metastatic breast cancer after first-line treatment with bevacizumab plus chemotherapy (TANIA): an open-label, rando